Overall Score

Revenue Quality

TTM revenue remains modest at $0.24/share with a very low gross margin of 6.5%, limiting the ability to convert sales into profit.

Revenue generation is still weak relative to the asset base, with asset turnover at 0.44x and operating margins deeply negative.

Profitability

TTM profitability remains severely negative, with net margin at -153.1%, operating margin at -153.5%, and EBITDA margin at -141.4%.

Returns on capital are deeply negative, including ROIC at -96.8% and ROE at -118.1%, indicating the business is still destroying capital.

Cash Conversion

Operating cash flow and free cash flow remain negative, with FCF per share at -$0.25 and FCF yield still negative.

Working capital is positive and the current ratio is 1.73x, but cash generation remains insufficient to support the business model.

Balance Sheet

Liquidity is acceptable with a current ratio of 1.73x and quick ratio of 1.60x, giving the company some near-term flexibility.

Leverage appears manageable at this scale, with debt-to-equity at 0.73x and net debt to EBITDA near zero, though profitability remains too weak to meaningfully de-risk the balance sheet.

Scalability

The cost structure remains heavy, with R&D at 107.1% of revenue and SG&A at 52.9% of revenue, leaving little room for operating leverage.

Inventory and receivables efficiency are mixed, with DSO at 94.6 days and operating cycle at 134.0 days, suggesting working-capital intensity remains elevated.